Journal articles
Forsyth J, Barron N, Scott L, Bridget W, Chisnall M, Meaden S, Van Houte S, Raymond B (In Press). Decolonizing drug-resistant E. coli with phage and probiotics: breaking the frequency-dependent dominance of residents.
MicrobiologyAbstract:
Decolonizing drug-resistant E. coli with phage and probiotics: breaking the frequency-dependent dominance of residents
Widespread antibiotic resistance in commensal bacteria creates a persistent challenge for human health. Resident drug-resistant microbes can prevent clinical interventions, colonize wounds post-surgery, pass resistance traits to pathogens or move to more harmful niches following routine interventions such as catheterization. Accelerating the removal of resistant bacteria or actively decolonizing particular lineages from hosts could therefore have a number of long-term benefits. However, removing resident bacteria via competition with probiotics, for example, poses a number of ecological challenges. Resident microbes are likely to have physiological and numerical advantages and competition based on bacteriocins or other secreted antagonists is expected to give advantages to the dominant partner, via positive frequency dependence. Since a narrow range of E. coli genotypes (primarily those belonging to the clonal group ST131) cause a significant proportion of multi-drug resistant infections, this group presents a promising target for decolonization with bacteriophage, as narrow host range viral predation could lead to selective removal of particular genotypes. In this study we tested how a combination of a ST131-specific phage and competition from the well-known probiotic E. coli Nissle strain could displace E. coli ST131 under aerobic and anaerobic growth conditions in vitro. We showed that the addition of phage could break the frequency-dependent advantage of a numerically dominant ST131 isolate. Moreover, the addition of competing E. coli Nissle could improve the ability of phage to suppress ST131 by two orders of magnitude. Low-cost phage resistance evolved readily in these experiments and was not inhibited by the presence of a probiotic competitor. Nevertheless, combinations of phage and probiotic produced stable long-term suppression of ST131 over multiple transfers and under both aerobic and anaerobic growth conditions. Combinations of phage and probiotic therefore have real potential for accelerating the removal of drug resistant commensal targets.
Abstract.
Watson BNJ, Pursey E, Gandon S, Westra ER (2023). Transient eco-evolutionary dynamics early in a phage epidemic have strong and lasting impact on the long-term evolution of bacterial defences.
PLoS Biol,
21(9).
Abstract:
Transient eco-evolutionary dynamics early in a phage epidemic have strong and lasting impact on the long-term evolution of bacterial defences.
Organisms have evolved a range of constitutive (always active) and inducible (elicited by parasites) defence mechanisms, but we have limited understanding of what drives the evolution of these orthogonal defence strategies. Bacteria and their phages offer a tractable system to study this: Bacteria can acquire constitutive resistance by mutation of the phage receptor (surface mutation, sm) or induced resistance through their CRISPR-Cas adaptive immune system. Using a combination of theory and experiments, we demonstrate that the mechanism that establishes first has a strong advantage because it weakens selection for the alternative resistance mechanism. As a consequence, ecological factors that alter the relative frequencies at which the different resistances are acquired have a strong and lasting impact: High growth conditions promote the evolution of sm resistance by increasing the influx of receptor mutation events during the early stages of the epidemic, whereas a high infection risk during this stage of the epidemic promotes the evolution of CRISPR immunity, since it fuels the (infection-dependent) acquisition of CRISPR immunity. This work highlights the strong and lasting impact of the transient evolutionary dynamics during the early stages of an epidemic on the long-term evolution of constitutive and induced defences, which may be leveraged to manipulate phage resistance evolution in clinical and applied settings.
Abstract.
Author URL.
Watson BNJ, Steens JA, Staals RHJ, Westra ER, van Houte S (2021). Coevolution between bacterial CRISPR-Cas systems and their bacteriophages.
Cell Host Microbe,
29(5), 715-725.
Abstract:
Coevolution between bacterial CRISPR-Cas systems and their bacteriophages.
CRISPR-Cas systems provide bacteria and archaea with adaptive, heritable immunity against their viruses (bacteriophages and phages) and other parasitic genetic elements. CRISPR-Cas systems are highly diverse, and we are only beginning to understand their relative importance in phage defense. In this review, we will discuss when and why CRISPR-Cas immunity against phages evolves, and how this, in turn, selects for the evolution of immune evasion by phages. Finally, we will discuss our current understanding of if, and when, we observe coevolution between CRISPR-Cas systems and phages, and how this may be influenced by the mechanism of CRISPR-Cas immunity.
Abstract.
Author URL.
Rollie C, Chevallereau A, Watson BNJ, Chyou T-Y, Fradet O, McLeod I, Fineran PC, Brown CM, Gandon S, Westra ER, et al (2020). Publisher Correction: Targeting of temperate phages drives loss of type I CRISPR-Cas systems.
Nature,
579(7799).
Abstract:
Publisher Correction: Targeting of temperate phages drives loss of type I CRISPR-Cas systems.
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Abstract.
Author URL.
Rollie C, Chevallereau A, Watson BNJ, Chyou T-Y, Fradet O, McLeod I, Fineran PC, Brown CM, Gandon S, Westra ER, et al (2020). Targeting of temperate phages drives loss of type I CRISPR–Cas systems. Nature, 578(7793), 149-153.
Hampton HG, Watson BNJ, Fineran PC (2020). The arms race between bacteria and their phage foes.
Nature,
577(7790), 327-336.
Abstract:
The arms race between bacteria and their phage foes
Bacteria are under immense evolutionary pressure from their viral invaders—bacteriophages. Bacteria have evolved numerous immune mechanisms, both innate and adaptive, to cope with this pressure. The discovery and exploitation of CRISPR–Cas systems have stimulated a resurgence in the identification and characterization of anti-phage mechanisms. Bacteriophages use an extensive battery of counter-defence strategies to co-exist in the presence of these diverse phage defence mechanisms. Understanding the dynamics of the interactions between these microorganisms has implications for phage-based therapies, microbial ecology and evolution, and the development of new biotechnological tools. Here we review the spectrum of anti-phage systems and highlight their evasion by bacteriophages.
Abstract.
Watson BNJ, Easingwood RA, Tong B, Wolf M, Salmond GPC, Staals RHJ, Bostina M, Fineran PC (2019). Different genetic and morphological outcomes for phages targeted by single or multiple CRISPR-Cas spacers. Philosophical Transactions of the Royal Society B Biological Sciences, 374(1772).
Watson BNJ, Vercoe RB, Salmond GPC, Westra ER, Staals RHJ, Fineran PC (2019). Type I-F CRISPR-Cas resistance against virulent phage infection triggers abortive infection and provides population-level immunity.
Abstract:
Type I-F CRISPR-Cas resistance against virulent phage infection triggers abortive infection and provides population-level immunity
Type I CRISPR-Cas systems are the most abundant and widespread adaptive immune systems of bacteria and can greatly enhance bacterial survival in the face of temperate phage infection. However, it is less clear how these systems protect against virulent phages. Here we experimentally show that type I CRISPR immunity of Pectobacterium atrosepticum leads to rapid suppression of two unrelated virulent phages, ΦTE and ΦM1. However, unlike the case where bacteria are infected with temperate phages, this is the result of an abortive infection-like phenotype, where infected cells do not survive the infection but instead become metabolically inactive and lose their membrane integrity. Our findings challenge the view of CRISPR-Cas as a system that protects the individual cell and supports growing evidence of an Abi-like function for some types of CRISPR-Cas systems.
Abstract.
Watson BNJ, Vercoe RB, Salmond GPC, Westra ER, Staals RHJ, Fineran PC (2019). Type I-F CRISPR-Cas resistance against virulent phages results in abortive infection and provides population-level immunity.
Nat Commun,
10(1).
Abstract:
Type I-F CRISPR-Cas resistance against virulent phages results in abortive infection and provides population-level immunity.
Type I CRISPR-Cas systems are abundant and widespread adaptive immune systems in bacteria and can greatly enhance bacterial survival in the face of phage infection. Upon phage infection, some CRISPR-Cas immune responses result in bacterial dormancy or slowed growth, which suggests the outcomes for infected cells may vary between systems. Here we demonstrate that type I CRISPR immunity of Pectobacterium atrosepticum leads to suppression of two unrelated virulent phages, ɸTE and ɸM1. Immunity results in an abortive infection response, where infected cells do not survive, but viral propagation is severely decreased, resulting in population protection due to the reduced phage epidemic. Our findings challenge the view of CRISPR-Cas as a system that protects the individual cell and supports growing evidence of abortive infection by some types of CRISPR-Cas systems.
Abstract.
Author URL.
Watson BNJ, Staals RHJ, Fineran PC (2018). CRISPR-Cas-Mediated Phage Resistance Enhances Horizontal Gene Transfer by Transduction. mBio, 9(1), e02406-e02417.
Pawluk A, Staals RHJ, Taylor C, Watson BNJ, Saha S, Fineran PC, Maxwell KL, Davidson AR (2016). Inactivation of CRISPR-Cas systems by anti-CRISPR proteins in diverse bacterial species. Nature Microbiology, 1(8).
Richter C, Dy RL, McKenzie RE, Watson BNJ, Taylor C, Chang JT, McNeil MB, Staals RHJ, Fineran PC (2014). Priming in the Type I-F CRISPR-Cas system triggers strand-independent spacer acquisition, bi-directionally from the primed protospacer. Nucleic Acids Research, 42(13), 8516-8526.
McNeil MB, Hampton HG, Hards KJ, Watson BNJ, Cook GM, Fineran PC (2013). The succinate dehydrogenase assembly factor, SdhE, is required for the flavinylation and activation of fumarate reductase in bacteria. FEBS Letters, 588(3), 414-421.